Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients
Table 3
Major clinicopathological features of 4 patients with OS over 10 years.
No
Age (y)
KPS score
Histopathology
CRS
HIPEC
PCI score
CC score
Recurrence
Survival status
OS (mo)
1
41
100
High-grade serous carcinoma
Hysterectomy and resection of bilateral ovarian/fallopian tubes, pelvic lymphadenectomy, ascending colon resection, sigmoidectomy, left and right diaphragmatic peritoneum, greater/lesser omentectomy, round ligament of liver resection, right paracolic sulci peritoneum, mesenteric fulguration
19
1
No
Survival
149.2
2
52
90
High-grade serous carcinoma
Hysterectomy and resection of bilateral ovarian/fallopian tube, pelvic lymphadenectomy, greater/lesser omentectomy
MMC 40 mg
13
1
No
Survival
129.9
3
49
80
High-grade serous carcinoma
Hysterectomy and resection of bilateral ovarian/fallopian tube, pelvic lymphadenectomy, sigmoidectomy, cholecystectomy, greater/lesser omentectomy
11
1
No
Survival
121.5
4
32
80
High-grade serous carcinoma
Hysterectomy and resection of bilateral ovarian/fallopian tubes, pelvic lymphadenectomy, greater/lesser omentectomy
